| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
3e-19 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-17 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
3e-16 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-12 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-12 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-11 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-11 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-11 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-10 |